rho GDP Dissociation Inhibitor (GDI) gamma (ARHGDIG) Peptide
ARHGDIG
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all ARHGDIG products
- ARHGDIG (rho GDP Dissociation Inhibitor (GDI) gamma (ARHGDIG))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- DEAVPEYRAP GRKSLLEIRQ LDPDDRSLAK YKRVLLGPLP PAVDPSLPN
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ARHGDIG antibody,
Alternative Names: ARHGDIG control peptide, ARHGDIG antibody Blocking Peptide, Anti-ARHGDIG Blocking Peptide, Rho Gdp Dissociation Inhibitor Blocking Peptide, Gdi Gamma Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- ARHGDIG (rho GDP Dissociation Inhibitor (GDI) gamma (ARHGDIG))
- Background
- ARHGDIG is highly expressed in the entire brain, with regional variations. The mRNA is also present at high levels in kidney and pancreas and at moderate levels in spinal cord, stomach, and pituitary gland. ARHGDIG is mapped to chromosome band 16p13.3 which is rich in deletion mutants of genes involved in several human diseases, notably polycystic kidney disease, alpha-thalassemia, tuberous sclerosis, mental retardation, and cancer.
- Molecular Weight
- 25 kDa
-
You are here:
